PCA
TMO icon

Private Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Private Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14M Sell
27,861
-43
-0.2% -$20.6K 1.22% 20
2026
Q1 		$13.7M Buy
27,904
+145
+0.5% +$78.7K 1.57% 16
2025
Q4 		$16.1M Sell
27,759
-1,020
-4% -$577K 1.64% 11
2025
Q3 		$14M Sell
28,779
-735
-2% -$342K 1.55% 19
2025
Q2 		$12M Sell
29,514
-431
-1% -$180K 1.46% 17
2025
Q1 		$14.9M Sell
29,945
-372
-1% -$201K 1.78% 14
2024
Q4 		$15.8M Buy
30,317
+4
+0% +$2.2K 1.88% 14
2024
Q3 		$18.8M Buy
30,313
+543
+2% +$321K 2.05% 10
2024
Q2 		$16.5M Sell
29,770
-200
-0.7% -$115K 1.83% 10
2024
Q1 		$17.4M Sell
29,970
-65
-0.2% -$36.5K 2.17% 8
2023
Q4 		$15.9M Buy
30,035
+17
+0.1% +$8.23K 2.43% 6
2023
Q3 		$13.4M Sell
30,018
-189
-0.6% -$101K 2.06% 9
2023
Q2 		$15.8M Sell
30,207
-1,590
-5% -$858K 2.58% 7
2023
Q1 		$18.3M Sell
31,797
-9,285
-23% -$5.23M 3.45% 4
2022
Q4 		$22.6M Sell
41,082
-12
-0% -$6.36K 3.88% 4
2022
Q3 		$20.8M Buy
41,094
+84
+0.2% +$47K 3.61% 5
2022
Q2 		$22.3M Buy
41,010
+3,748
+10% +$2.06M 3.75% 5
2022
Q1 		$22M Buy
37,262
+501
+1% +$288K 3.2% 6
2021
Q4 		$24.5M Sell
36,761
-60
-0.2% -$37.5K 3.91% 5
2021
Q3 		$21M Hold
36,821
– – 3.5% 5
2021
Q2 		$18.6M Sell
36,821
-273
-0.7% -$129K 3.14% 5
2021
Q1 		$16.9M Hold
37,094
– – 3.16% 4
2020
Q4 		$17.3M Hold
37,094
– – 3.49% 4
2020
Q3 		$16.4M Sell
37,094
-90
-0.2% -$37.2K 3.8% 4
2020
Q2 		$13.5M Hold
37,184
– – 3.49% 7
2020
Q1 		$10.5M Sell
37,184
-330
-0.9% -$104K 3.34% 10
2019
Q4 		$12.2M Sell
37,514
-250
-0.7% -$75.8K 2.99% 11
2019
Q3 		$11M Sell
37,764
-1,156
-3% -$331K 3.06% 6
2019
Q2 		$11.4M Hold
38,920
– – 3.23% 6
2019
Q1 		$10.7M Sell
38,920
-83
-0.2% -$20.7K 3.22% 6
2018
Q4 		$8.73M Buy
39,003
+13
+0% +$3.05K 3.13% 6
2018
Q3 		$9.52M Buy
38,990
+252
+0.7% +$58K 2.63% 9
2018
Q2 		$8.02M Buy
38,738
+454
+1% +$96.4K 2.51% 9
2018
Q1 		$7.9M Sell
38,284
-235
-0.6% -$49.3K 2.63% 9
2017
Q4 		$7.31M Sell
38,519
-4,027
-9% -$771K 2.54% 11
2017
Q3 		$8.05M Sell
42,546
-390
-0.9% -$70.6K 2.75% 7
2017
Q2 		$7.49M Sell
42,936
-1,360
-3% -$228K 2.42% 8
2017
Q1 		$6.8M Sell
44,296
-1,360
-3% -$208K 2.22% 13
2016
Q4 		$6.44M Buy
45,656
+151
+0.3% +$22.3K 2.21% 13
2016
Q3 		$7.24M Buy
45,505
+175
+0.4% +$27K 2.58% 9
2016
Q2 		$6.7M Sell
45,330
-450
-1% -$66.4K 2.53% 8
2016
Q1 		$6.48M Sell
45,780
-155
-0.3% -$20.8K 2.89% 7
2015
Q4 		$6.52M Sell
45,935
-200
-0.4% -$26.7K 2.81% 6
2015
Q3 		$5.64M Sell
46,135
-95
-0.2% -$12.4K 2.36% 10
2015
Q2 		$6M Buy
+46,230
New +$6.03M 1.96% 14

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Private Capital Advisors's TMO Position: Q2 2026 in Review

Private Capital Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.15% in Q2 2026, selling an estimated $20.6K and leaving 27,861 shares worth $14M. The position accounts for 1.22% of the portfolio, ranked #20.

Private Capital Advisors first reported a position in TMO in Q2 2015 and has held it in 45 quarters since. The position peaked at $24.5M in Q4 2021. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Private Capital Advisors held 27,861 shares of Thermo Fisher Scientific worth $14M as of Q2 2026.
  • Private Capital Advisors sold 43 Thermo Fisher Scientific shares in Q2 2026, an estimated $20.6K.
  • Thermo Fisher Scientific made up 1.22% of Private Capital Advisors's portfolio in Q2 2026, its #20 holding.
  • Private Capital Advisors first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 45 quarters since.
  • Private Capital Advisors's Thermo Fisher Scientific position peaked at $24.5M in Q4 2021.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Private Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.